(PRWEB) February 04, 2013
The Rottenstein Law Group monitors NuvaRing lawsuits carefully following a report that bellwether trials were delayed until July 2013. The multidistrict litigation (MDL - 1964) was created in the U.S. District Court for the Eastern District of Missouri and assigned to Judge Rodney W. Sippel to consolidate pretrial proceedings after more than 1,000 NuvaRing lawsuits were filed by claimants across the country. The first trials were originally set to begin in 2012, but were postponed on several occasions. The Rottenstein Law Group maintains a NuvaRing Lawsuit Information Center to help those who believe they have been injured best determine the next steps for determining if they have a case.
“It’s unfortunate that the first trials have been pushed back,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, “because it puts off the potential recovery for the injured, but if the delay means that the parties will be better prepared to present their cases to the court, then additional time can be a good thing.”
NuvaRing, manufactured by Merck, first came into the U.S. market in July 2002. The flexible, plastic ring birth control apparatus is a combined contraceptive device, which means that its slow release is a low dose of more than one hormone, in this case progestin and estrogen. That combined hormonal configuration is responsible for the increased blood clot risk, according to an FDA report.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com